Search Results - "Todd Gillespie"
-
1
Direct Molecular Analysis of Whole-Body Animal Tissue Sections by Imaging MALDI Mass Spectrometry
Published in Analytical chemistry (Washington) (15-09-2006)“…Imaging mass spectrometry (IMS) that utilizes matrix-assisted laser desorption/ionization (MALDI) technology can provide a molecular ex vivo view of resected…”
Get full text
Journal Article -
2
The Disposition of Prasugrel, a Novel Thienopyridine, in Humans
Published in Drug metabolism and disposition (01-07-2007)“…Prasugrel, a prodrug, is a novel and potent inhibitor of platelet aggregation in vivo. The metabolism of prasugrel and the elimination and pharmacokinetics of…”
Get full text
Journal Article -
3
Mass spectrometry for small molecule pharmaceutical product development: A review
Published in Mass spectrometry reviews (01-05-2011)“…Developing a pharmaceutical product has become increasingly difficult and expensive. With an emphasis on developing project knowledge at an earlier stage in…”
Get full text
Journal Article -
4
A review of nanoelectrospray ionization applications for drug metabolism and pharmacokinetics
Published in Current drug metabolism (01-12-2006)“…Although traditionally reserved for proteomic analysis, nanoESI has found increased use for small molecule applications related to drug…”
Get more information
Journal Article -
5
Identification of Aliphatic and Aromatic Tertiary N-Oxide Functionalities in Protonated Analytes via Ion/Molecule and Dissociation Reactions in an FT-ICR Mass Spectrometer
Published in Journal of organic chemistry (06-02-2009)“…A mass spectrometric method is presented for the identification of compounds that contain the aliphatic or aromatic N-oxide functional group. This method…”
Get full text
Journal Article -
6
Identification of the Aromatic Tertiary N-Oxide Functionality in Protonated Analytes via Ion/Molecule Reactions in Mass Spectrometers
Published in Journal of organic chemistry (04-07-2008)“…A mass spectrometric method is presented for the rapid identification of compounds that contain the aromatic N-oxide functional group. This method utilizes a…”
Get full text
Journal Article -
7
Identification and Counting of Carbonyl and Hydroxyl Functionalities in Protonated Bifunctional Analytes by Using Solution Derivatization Prior to Mass Spectrometric Analysis Via Ion-Molecule Reactions
Published in Journal of the American Society for Mass Spectrometry (01-05-2010)“…A mass spectrometric method has been developed for the identification of carbonyl and hydroxyl functional groups, as well as for counting the functional…”
Get full text
Journal Article -
8
APPLICATION OF BIOCATALYSIS TO DRUG METABOLISM: PREPARATION OF MAMMALIAN METABOLITES OF A BIARYL-BIS-SULFONAMIDE AMPA (α-AMINO-3-HYDROXY-5-METHYLISOXAZOLE-4-PROPIONIC ACID) RECEPTOR POTENTIATOR USING Actinoplanes missouriensis
Published in Drug metabolism and disposition (01-06-2006)“…LY451395 (2-propanesulfonamide, N -[(2 R )-2-[4â²-[2-[methylsulfonyl)amino]ethyl][1,1â²-biphenyl]-4-yl]propyl]-) is a potent and highly selective potentiator…”
Get full text
Journal Article -
9
Disposition and Biotransformation of the Antipsychotic Agent Olanzapine in Humans
Published in Drug metabolism and disposition (01-01-1997)“…Disposition and biotransformation of the new antipsychotic agent olanzapine (OLZ) were studied in six male healthy volunteers after a single oral dose of 12.5…”
Get full text
Journal Article -
10
The disposition and metabolism of naveglitazar, a peroxisome proliferator-activated receptor α-γ dual, γ-dominant agonist in mice, rats, and monkeys
Published in Drug metabolism and disposition (2007)“…Naveglitazar [LY519818; benzenepropanoic acid, alpha-methoxy-4-[3-(4-phenoxyphenoxy)propoxy], (alpha-S)-] is a nonthiozolidinedione peroxisome…”
Get full text
Journal Article -
11
Three-dimensional quantitative structure activity relationship analyses of substrates for CYP2B6
Published in The Journal of pharmacology and experimental therapeutics (01-01-1999)“…To begin to build an understanding of the interactions of CYP2B6 with substrates, two different 3-dimensional quantitative structure activity relationship…”
Get more information
Journal Article -
12
Disposition and Metabolism of Olanzapine in Mice, Dogs, and Rhesus Monkeys
Published in Drug metabolism and disposition (01-05-1997)“…Olanzapine (OLZ) is a novel antipsychotic agent with a high affinity for serotonin (5-HT 2 ), dopamine (D 1 /D 2 /D 4 ), muscarinic (m 1 âm 5 ), adrenergic…”
Get full text
Journal Article -
13
The synthesis of (S)-di-n-propyl-(8-isoxazol-5-yl-1,2,3,4-tetrahydronaphthalen-2-yl)amine hydrochloride and its C-14-labeled isotopomer
Published in Journal of labelled compounds & radiopharmaceuticals (01-02-2005)“…The partial ergoline LY228729 (1) which was a potent 5HT1A agonist has been studied clinically. Somewhat later, a related analog,…”
Get full text
Journal Article -
14
Analysis of olanzapine in human plasma utilizing reversed-phase high-performance liquid chromatography with electrochemical detection
Published in Journal of chromatography. B, Biomedical applications (09-06-1995)“…A sensitive reversed-phase HPLC method for the analysis of olanzapine in human plasma is described. Isolation of olanzapine from plasma was accomplished by…”
Get full text
Journal Article -
15
Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine
Published in The Journal of pharmacology and experimental therapeutics (01-02-1996)“…The formation kinetics of 2-hydroxymethyl olanzapine (2-OH olanzapine), 4'-N-oxide olanzapine (N-O olanzapine) and 4'-N-desmethyl olanzapine (NdM olanzapine)…”
Get more information
Journal Article -
16
Olanzapine 10-N-glucuronide : A tertiary N-glucuronide unique to humans
Published in Drug metabolism and disposition (01-09-1998)“…In humans, a major metabolite of the atypical antipsychotic olanzapine in the plasma and in the urine was found to be an N-glucuronide. Unexpectedly, the…”
Get full text
Conference Proceeding Journal Article -
17
Pergolide: multiple-dose pharmacokinetics in patients with mild to moderate Parkinson disease
Published in Clinical neuropharmacology (01-05-2005)“…The primary objective of this study was to describe the pharmacokinetics of oral pergolide in patients with mild to moderate Parkinson disease using a new…”
Get full text
Journal Article -
18
Determination of the muscarinic agent [(3-(3-1-butylthio)-1,2,5-thiadiazol-4-yl)-1-azabicyclo[2.2.2]octane], in rat, rabbit, and monkey plasma, using high-performance liquid chromatography in conjunction with tandem mass spectrometry
Published in Journal of chromatography. Biomedical applications (03-11-1995)“…A method for determining a selective muscarinic agent, LY297802 (compound I), [(3-(3-1-butylthio)-1,2,5-thiadiazol-4-yl)-1-azabicyclo[2.2.2]octane], indicated…”
Get full text
Journal Article -
19
Olanzapine 10-N-Glucuronide
Published in Drug metabolism and disposition (01-09-1998)“…In humans, a major metabolite of the atypical antipsychotic olanzapine in the plasma and in the urine was found to be an N -glucuronide. Unexpectedly, the…”
Get full text
Journal Article -
20